Overcoming ABCG2-mediated drug resistance with imidazo-[1,2-b]-pyridazine-based Pim1 kinase inhibitors
Crossref DOI link: https://doi.org/10.1007/s00280-015-2858-9
Published Online: 2015-09-09
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Darby, Richard A. J.
Unsworth, Amanda
Knapp, Stefan
Kerr, Ian D.
Callaghan, Richard
Funding for this research was provided by:
Wellcome Trust (090072/Z/09/Z, 092809/Z/10/Z)
Text and Data Mining valid from 2015-09-09